Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$768M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$625M |
| 3 |
AGN
Allergan plc
AGN
|
+$427M |
| 4 |
McKesson
MCK
|
+$427M |
| 5 |
Johnson Controls International
JCI
|
+$427M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$503M |
| 2 |
RTX Corp
RTX
|
+$457M |
| 3 |
Global Payments
GPN
|
+$441M |
| 4 |
Amazon
AMZN
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.1% |
| 2 | Healthcare | 3.97% |
| 3 | Industrials | 2.85% |
| 4 | Financials | 2.77% |
| 5 | Consumer Discretionary | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Texas Pacific Land
TPL
$27.6B
| $9.74M | ﹤0.01% |
230,679
+113,508
| +97% | +$8.31M |
|
|
ICPT
1752
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.72M | ﹤0.01% |
154,400
-232,800
| -60% | -$20.9M |
|
1753
Post Holdings
POST
$4.15B
| $9.71M | ﹤0.01% |
178,811
+59,691
| +50% | +$3.88M |
|
1754
Thor Industries
THO
$3.99B
| $9.71M | ﹤0.01% |
230,097
+10,691
| +5% | +$742K |
|
1755
iShares US Financial Services ETF
IYG
$2.19B
| $9.7M | ﹤0.01% |
283,431
+25,776
| +10% | +$1.18M |
|
1756
Newell Brands
NWL
$2.58B
| $9.7M | ﹤0.01% |
730,208
-307,972
| -30% | -$5.3M |
|
1757
Plains GP Holdings
PAGP
$5.16B
| $9.65M | ﹤0.01% |
1,720,950
+1,026,638
| +148% | +$14.4M |
|
1758
PUT
T. Rowe Price
TROW
$24.4B
| $9.65M | ﹤0.01% |
98,800
+62,000
| +168% | +$7.59M |
|
|
BSJL
1759
DELISTED
Invesco BulletShares 2021 High Yield Corporate Bond ETF
BSJL
| $9.64M | ﹤0.01% |
+435,635
| New | +$10.4M |
|
1760
CALL
Zebra Technologies
ZBRA
$13.8B
| $9.64M | ﹤0.01% |
52,500
+14,100
| +37% | +$3.17M |
|
|
GBT
1761
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $9.64M | ﹤0.01% |
188,594
+1,244
| +0.7% | +$83.3K |
|
1762
Alerian MLP ETF
AMLP
$12.9B
| $9.61M | ﹤0.01% |
558,865
-237,821
| -30% | -$8.06M |
|
1763
CALL
DaVita
DVA
$15.3B
| $9.61M | ﹤0.01% |
126,300
-105,900
| -46% | -$8.33M |
|
1764
CALL
LyondellBasell Industries
LYB
$19.9B
| $9.6M | ﹤0.01% |
193,500
-16,000
| -8% | -$1.18M |
|
|
1765
CALL
T. Rowe Price
TROW
$24.4B
| $9.6M | ﹤0.01% |
98,300
+15,100
| +18% | +$1.85M |
|
1766
FirstEnergy
FE
$28.1B
| $9.58M | ﹤0.01% |
239,191
+151,368
| +172% | +$7.03M |
|
1767
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.96B
| $9.58M | ﹤0.01% |
367,848
+337,232
| +1,101% | +$19M |
|
1768
PUT
ProShares UltraPro Short QQQ
SQQQ
$1.92B
| $9.58M | ﹤0.01% |
788
-459
| -37% | -$6.02M |
|
1769
Diamondback Energy
FANG
$56B
| $9.56M | ﹤0.01% |
364,916
-432,086
| -54% | -$27.2M |
|
|
1770
PUT
LyondellBasell Industries
LYB
$19.9B
| $9.55M | ﹤0.01% |
192,500
+72,500
| +60% | +$5.33M |
|
1771
CALL
New Oriental
EDU
$9.45B
| $9.55M | ﹤0.01% |
88,200
-3,700
| -4% | -$475K |
|
1772
Criteo S.A. Ordinary Shares
CRTO
$1.07B
| $9.55M | ﹤0.01% |
1,200,779
+309,905
| +35% | +$3.95M |
|
1773
Ross Stores
ROST
$81.1B
| $9.52M | ﹤0.01% |
109,500
-920,036
| -89% | -$98.3M |
|
1774
iShares Convertible Bond ETF
ICVT
$7.31B
| $9.51M | ﹤0.01% |
174,971
+157,077
| +878% | +$9.72M |
|
1775
CALL
Takeda Pharmaceutical
TAK
$54.1B
| $9.5M | ﹤0.01% |
626,000
-99,800
| -14% | -$1.81M |
|
Similar funds
Citadel Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Citadel Advisors held 10,687 positions worth $222B, down 3.5% from $230B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors deployed $36.9B of net new capital in Q1 2020, opening 1,650 new positions and adding to 4,224 existing holdings. Its largest new stake was Invesco QQQ Trust: 2,950,335 shares worth $562M.
By sector, the portfolio is most concentrated in Technology at 4.1% of assets, down from 5.1% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Uber, an estimated $503M trimmed.
- Citadel Advisors's largest Q1 2020 buy was Invesco QQQ Trust: 2,950,335 shares worth $562M.
- Citadel Advisors added most to Charter Communications in Q1 2020, an estimated $768M increase.
- Citadel Advisors's biggest Q1 2020 reduction was Uber, cutting an estimated $503M.
- Citadel Advisors fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $280M.
- Citadel Advisors's ten largest holdings make up 32% of its $222B portfolio in Q1 2020.
- Citadel Advisors opened 1,650 new positions and closed 1,165 in Q1 2020.
- Citadel Advisors's portfolio value fell 3.5% quarter-over-quarter to $222B.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.